Your browser doesn't support javascript.
loading
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model.
Huet, Simon; Zeisser Labouebe, Magali; Castro, Rute; Jacquot, Perrine; Pedrault, Jessy; Viollet, Sébastien; Van Simaeys, Gaetan; Doumont, Gilles; Larbanoix, Lionel; Zindy, Egor; Cunha, António E; Scapozza, Leonardo; Cinier, Mathieu.
Afiliación
  • Huet S; Affilogic SAS, Nantes, France.
  • Zeisser Labouebe M; Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
  • Castro R; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
  • Jacquot P; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
  • Pedrault J; Affilogic SAS, Nantes, France.
  • Viollet S; Affilogic SAS, Nantes, France.
  • Van Simaeys G; Affilogic SAS, Nantes, France.
  • Doumont G; CMMI, Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi (Gosselies), Belgium.
  • Larbanoix L; CMMI, Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi (Gosselies), Belgium.
  • Zindy E; CMMI, Center for Microscopy and Molecular Imaging, Université de Mons, Charleroi (Gosselies), Belgium.
  • Cunha AE; CMMI, Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Charleroi (Gosselies), Belgium.
  • Scapozza L; iBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
  • Cinier M; Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
Mol Cancer Ther ; 22(11): 1343-1351, 2023 Nov 01.
Article en En | MEDLINE | ID: mdl-37578807
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article País de afiliación: Francia